世界の薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）市場：市場規模・現状・予測

• 英文タイトル：Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7816 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日）

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）のグローバル市場について調査・分析したレポートで、種類別（腫瘍学、神経学的障害、循環器疾患、免疫疾患、その他）、用途別（キアゲンNV、GEヘルスケア、アジレントテクノロジー、Fホフマンラロッシュ、基礎医学、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の世界市場規模 ・主要企業別市場シェア ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の世界市場規模：種類別（腫瘍学、神経学的障害、循環器疾患、免疫疾患、その他） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の世界市場規模：用途別（キアゲンNV、GEヘルスケア、アジレントテクノロジー、Fホフマンラロッシュ、基礎医学、その他） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）のアメリカ市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）のヨーロッパ市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の中国市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の日本市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の東南アジア市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）のインド市場規模（種類別、用途別） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の世界市場予測（2019年-2025年） ・薬理ゲノム学技術/セラノスティックス/コンパニオン診断薬（CDx）の地域別市場予測（2019年-2025年） ...

In 2018, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development in United States, Europe and China.

The key players covered in this study
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer

Market segment by Type, the product can be split into
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

Market segment by Application, split into
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) status, future forecast, growth opportunity, key market and key players.
To present the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR
1.4.3 In-situ Hybridization
1.4.4 Immunohistochemistry
1.4.5 Sequencing
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Neurological Disorders
1.5.4 Cardiovascular Disease
1.5.5 Immunological Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size
2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Growth Trends by Regions
2.2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2014-2025)
2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Manufacturers
3.1.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players Head office and Area Served
3.3 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service
3.4 Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019)

5 United States
5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
5.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in United States
5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
5.4 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

6 Europe
6.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
6.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Europe
6.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
6.4 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

7 China
7.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
7.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in China
7.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
7.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

8 Japan
8.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
8.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Japan
8.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
8.4 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
9.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Southeast Asia
9.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
9.4 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

10 India
10.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
10.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in India
10.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
10.4 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

11 Central & South America
11.1 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2014-2019)
11.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Central & South America
11.3 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
11.4 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

12 International Players Profiles
12.1 Qiagen NV
12.1.1 Qiagen NV Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.1.4 Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.1.5 Qiagen NV Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.2.4 GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.2.5 GE Healthcare Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.3.5 Agilent Technologies Recent Development
12.4 F Hoffman La Roche
12.4.1 F Hoffman La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.4.5 F Hoffman La Roche Recent Development
12.5 Foundation Medicine
12.5.1 Foundation Medicine Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.5.5 Foundation Medicine Recent Development
12.6 Thermo Fisher Scientific Inc.
12.6.1 Thermo Fisher Scientific Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.6.5 Thermo Fisher Scientific Inc. Recent Development
12.7 Leica Biosystems Nussloch GmBH
12.7.1 Leica Biosystems Nussloch GmBH Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.7.5 Leica Biosystems Nussloch GmBH Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
12.8.4 Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
12.8.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Market Segments
Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Covered
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type 2014-2025
Figure PCR Figures
Table Key Players of PCR
Figure In-situ Hybridization Figures
Table Key Players of In-situ Hybridization
Figure Immunohistochemistry Figures
Table Key Players of Immunohistochemistry
Figure Sequencing Figures
Table Key Players of Sequencing
Figure Others Figures
Table Key Players of Others
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth by Application 2014-2025 (Million US$)
Figure Oncology Case Studies
Figure Neurological Disorders Case Studies
Figure Cardiovascular Disease Case Studies
Figure Immunological Disorders Case Studies
Figure Others Case Studies
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report Years Considered
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2025 (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2014-2025 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2014-2019 (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2014-2019
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2014-2019
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2019
Table Market Top Trends
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers (2014-2019)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers in 2018
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service
Table Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type (2014-2019)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type (2014-2019)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2014-2019)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Application (2014-2019)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Application in 2018
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-20189) (Million US$)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2018-2019)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2014-2019)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2014-2019)
Table Qiagen NV Company Details
Table Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019) (Million US$)
Figure Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Qiagen NV Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table GE Healthcare Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Agilent Technologies Recent Development
Table F Hoffman La Roche Company Details
Table F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table F Hoffman La Roche Recent Development
Table Foundation Medicine Company Details
Table Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Foundation Medicine Recent Development
Table Thermo Fisher Scientific Inc. Company Details
Table Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Thermo Fisher Scientific Inc. Recent Development
Table Leica Biosystems Nussloch GmBH Company Details
Table Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Leica Biosystems Nussloch GmBH Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2014-2019)
Table Pfizer Recent Development
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (Million US$) 2019-2025
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions (2019-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions in 2025
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2019-2025)(Million USD)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2019-2025) (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2019-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product in 2025
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2019-2025) (Million US$)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2019-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---